We have developed a system for generation of infectious bursal disease virus (IBDV), a segmented doublestranded RNA virus of the Birnaviridae family, with the use of synthetic transcripts derived from cloned cDNA. Independent full-length cDNA clones were constructed that contained the entire coding and noncoding regions of RNA segments A and B of two distinguishable IBDV strains of serotype I. Segment A encodes all of the structural (VP2, VP4, and VP3) and nonstructural (VP5) proteins, whereas segment B encodes the RNA-dependent RNA polymerase (VP1). Synthetic RNAs of both segments were produced by in vitro transcription of linearized plasmids with T7 RNA polymerase. Transfection of Vero cells with combined plus-sense transcripts of both segments generated infectious virus as early as 36 hr after transfection. The infectivity and specificity of the recovered chimeric virus was ascertained by the appearance of cytopathic effect in chicken embryo cells, by immunofluorescence staining of infected Vero cells with rabbit anti-IBDV serum, and by nucleotide sequence analysis of the recovered virus, respectively. In addition, transfectant viruses containing genetically tagged sequences in either segment A or segment B of IBDV were generated to confirm the feasibility of this system. The development of a reverse genetics system for double-stranded RNA viruses will greatly facilitate studies of the regulation of viral gene expression, pathogenesis, and design of a new generation of live vaccines.
Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, is the causative agent of a highly immunosuppressive disease in young chickens (1) . Two distinct serotypes of IBDV, designated as serotype I and serotype II, have been identified. The IBDV genome consists of two segments of double-stranded (ds)RNA that vary from 2827 (segment B) to 3261 (segment A) nucleotide base pairs (2) . The larger segment A encodes a polyprotein that is cleaved by autoproteolysis to form mature viral proteins VP2, VP3, and VP4 (3). VP2 and VP3 are the major structural proteins of the virion. VP2 is the major host-protective immunogen of IBDV and contains the antigenic regions responsible for the induction of neutralizing antibodies (4) . A second open reading frame (ORF), preceding and partially overlapping the polyprotein gene, encodes a protein (VP5) of unknown function that is present in IBDV-infected cells (5) . The smaller segment B encodes VP1, a 90-kDa multifunctional protein with polymerase and capping enzyme activities (6, 7) .
Although the nucleotide sequences for genome segments A and B of various IBDV strains have been published, it was only recently that the complete 5'-and 3'-noncoding sequences of both segments were determined. The 5'-noncoding region of IBDV segments A and B contains a consensus sequence of 32 nucleotides. The 3'-noncoding terminal sequences of both segments are unrelated, but they are conserved among IBDV strains of the same serotype (2) . These terminii may contain sequences important in packaging and in the regulation of IBDV gene expression, as demonstrated for other dsRNAcontaining viruses such as mamamlian and plant reoviruses and rotaviruses (8) (9) (10) .
In recent years, a number of infectious animal RNA viruses have been generated from cloned cDNA using transcripts produced by DNA-dependent RNA polymerase (11) . For example, poliovirus (a plus-stranded RNA virus), influenza virus (a segmented negative-stranded RNA virus), and rabies virus (a nonsegmented negative-stranded RNA virus) all were recovered from cloned cDNAs of their respective genomes (12) (13) (14) . For reovirus, it was shown that transfection of cells with a combination of single-stranded (ss)RNA, dsRNA, and in vitro translated reovirus products generated infectious reovirus when complemented with a helper virus of a different serotype (15) . However, to date, there is no report of a recovered infectious virus with a segmented dsRNA genome derived from synthetic RNAs only.
In an effort to develop a reverse genetics system for IBDV, we constructed two independent full-length cDNA clones that contain segment A of serotype I strain D78 and segment B of strain P2, respectively. Furthermore, these cDNA clones were modified by oligonucleotide-directed mutagenesis to generate the tagged sequences in each segment. Synthetic RNAs of segments A and B were produced by in vitro transcription reactions on linearized plasmids with T7 RNA polymerase. Transcripts of these segments, either untreated or treated with DNase or RNase, were evaluated for the generation of infectious virus by transfecting Vero cells.
MATERIALS AND METHODS
Viruses and Cells. Two serotype I strains of IBDV, the attenuated P2 strain from Germany and the vaccine strain D78 (Intervet, Millsboro, DE), were propagated in chicken embryo cells (CEC) and purified as described (2, 16) . Vero cells were grown in M199 medium supplemented with 5% fetal calf serum and used for transfection experiments. Further propagation of the recovered virus and immunofluorescence studies were carried out in Vero cells as described (5) . For plaque assay, monolayers of secondary CEC were prepared and used as described (17 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
11132 Microbiology: Mundt and Vakharia Construction of Full-Length cDNA Clones of IBDV Genome. Full-length cDNA clones of IBDV segments A and B were independently prepared. The cDNA clones containing the entire coding region of RNA segment A of strain D78 were prepared using standard cloning procedures and methods as described (16) . By comparing the D78 terminal sequences with recently published terminal sequences of other IBDV strains (2), it was observed that D78 cDNA clones lacked the conserved first 17 nucleotides at the 5' end and the last 10 nucleotides at the 3' ends. Therefore, to construct a full-length cDNA clone of segment A, two primer pairs (A5'-D78, A5-IPD78, and A3'D78, A3-4PD78) were synthesized and used for PCR amplification ( Table 1 ). The DNA segments were amplified according to the protocol of the supplier (New England Biolabs) using DeepVent polymerase. Amplified fragments were cloned into the EcoRI site of a pCRII vector (Invitrogen) to obtain plasmids pCRD78A5' and pCRD78A3'. Each plasmid was digested with EcoRI and SalI, and the resultant fragments were ligated into EcoRI digested-pUC19, to obtain plasmid pUC19FLAD78. This plasmid contains a full-length cDNA copy of segment A, which encodes all of the structural proteins (VP2, VP4, and VP3), as well as the nonstructural protein VP5 (Fig. 1) .
To obtain cDNA clones of segment B of P2 strain, two primer pairs (B5'-P2, B5-IPP2, and B3'-P2, B3-IPP2) were designed according to published sequences and used for reverse transcription (RT)-PCR amplification (see Table 1 ). Using genomic dsRNA as template, cDNA fragments were synthesized and amplified according to the supplier's protocol (Perkin-Elmer). Amplified fragments were blunt-end ligated into SmaI-cleaved pBS vector (Stratagene) to obtain clones pBSP2B5' and pBSP2B3'. To construct a full-length clone of segment B, the 5'-end fragment of plasmid pBSP2B5' was first subcloned between EcoRI and PstI sites of the pUC18 vector to obtain pUCP2B5'. Then the 3'-end fragment of plasmid pBSP2B3' was inserted between the unique BglII and PstI sites of plasmid pUCP2B5' to obtain a full-length plasmid pUC18FLBP2, which encodes VP1 protein (Fig. 1) . Plasmids pUC18FLBP2 and pUC19FLAD78 were completely sequenced by using the sequenase DNA sequencing system (United States Biochemical), and the sequence data was analyzed using either DNASIS (Pharmacia) or PC/GENE (IntelliGenetics) software. The integrity of the full-length constructs were tested by in vitro transcription and the translationcoupled reticulocyte lysate system using T7 RNA polymerase (Promega).
To introduce the sequence tags into segments A and B of IBDV, plasmids pUC19FLAD78mut and pUC18FLBP2mut were constructed by oligonucleotide-directed mutagenesis, using specific primer pairs and PCR amplification of their respective cDNA templates. To construct plasmid pUC19FLAD78mut, three primer pairs [RsrIIF, NheA(-); NheA(+), SpeA(-); and SpeA(+), SaclIR; see Table 1 ] were used to amplify the DNA fragments of 428, 655, and 623 bp, respectively. These fragments were combined and subsequently reamplified by PCR using the flanking primers (RsrIIF and SacIIR) to produce a 17Q6-bp fragment. This fragment was cloned into a pCRII vector to obtain plasmid pCRNhe-Spe. This plasmid was digested with RsrII and Sacll enzymes, and the resulting 1557-bp fragment was subcloned into unique RsrII and SacII sites of plasmid pUC19FLAD78. Finally, a mutant plasmid of segment A was obtained, which contains the unique NheI and SpeI restriction sites (nucleotide positions 545 and 1180, respectively). Similarly, plasmid pUC18FLBP2 was modified by PCR using an oligonucleotide primer containing three silent mutations. After amplification, the resulting fragment was digested with KpnI and BglII and cloned into KpnI-BglII-cleaved pUC18FLBP2. A mutant plasmid of segment B (pUC18FLBP2mut) was obtained, which contains the sequence tag (mutations at nucleotide positions 1770, 1773, and 1776).
Transcription and Transfection of Synthetic RNAs. Plasmids pUC19FLAD78, pUC18FLBP2, and their mutant cDNA clones were digested with BsrGI and PstI enzymes ( Fig. 1) , respectively, and used as templates for in vitro transcription with T7 RNA polymerase (Promega). Briefly, restriction enzyme cleavage assays were adjusted to 0.5% SDS and incubated with proteinase K (0.5 mg/ml) for 1 hr at 37°C. The linearized DNA templates (-3 ,tg) were recovered after ethanol precipitation, and were added separately to a transcription reaction mixture (50 ,l) containing 40 mM Tris HCl (pH 7.9), 10 mM NaCl, 6 mM MgCl2, 2 mM spermidine, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM UTP, 0.1 mM GTP, 0.25 mM cap analog [m7G(5')ppp(5')G], 120 units RNasin, 150 units T7 RNA polymerase (Promega), and incubated at 37°C for 1 hr.
Synthetic RNA transcripts were purified by phenol/ chloroform extraction and ethanol precipitation. As controls, the transcription products were treated with either DNase or RNase (Promega) before the purification step.
Vero cells were grown to 80% confluency in 60-mm dishes and washed once with phosphate-buffered saline (PBS). Three milliliters of OPTI-MEM I (GIBCO/BRL) were added to the monolayers, and the cells were incubated at 37°C for 1 hr in a CO2 incubator. Simultaneously, 0.15 ml of OPTI-MEM I was incubated with 12.5 jig of Lipofectin reagent (GIBCO/BRL) for 45 min in a polystyrene tube at room temperature. Synthetic RNA transcripts of both segments resuspended in 0.15 ml of diethyl pyrocarbonate-treated water, were added to the OPTI-MEM/Lipofectin mixture, mixed gently, and incubated on ice for 5 min. After removing the OPTI-MEM from the monolayers in the 60-mm dishes and replacing it with a fresh 1.5 ml of OPTI-MEM, the nucleic acid-containing mixture was added drop-wise to the Vero cells and swirled gently. After 2 hr of incubation at 37°C, the mixture was replaced with M199 medium containing 5% FCS (without rinsing the cells), and the cells were further incubated at 37°C for desired time intervals.
Identification of Generated IBDV. CEC were infected with the supernatant from Vero cells transfected with transcripts of either pUC18FLAD78, pUC18FLBP2, and/or their mutant plasmids. About 16 hr after infection, the whole cell nucleic acids were isolated as described (2) . Specific primers of segments A and B were used for RT of genomic RNA derived from these transfectant viruses. Following RT, the reaction products were amplified by PCR using specific primer pairs of segments A and B. Resulting PCR fragments were either cloned and sequenced as described before, or digested with appropriate restriction enzymes to identify the tagged sequences.
Immunofluorescence. Vero cells, grown on coverslips to 80% confluency, were infected with the supernatants derived from transfected Vero cells (after freeze thawing) and incubated at 37°C for 2 days. The cells were then washed, fixed with acetone, and treated with polyclonal rabbit anti-IBDV serum. After washing, the cells were treated with fluorescein labeled goat anti-rabbit antibody (Kirkegaard & Perry Laboratories) and examined by fluorescence microscopy.
Plaque Assay. Monolayers of secondary CEC, grown in 60-mm dishes, were inoculated with the supernatants derived from transfected Vero cells. One hour after infection, the cells were washed once with PBS, and overlaid with 0.8% noble Agar (Difco) containing 10% tryptose phosphate broth, 2% FCS, 0.112% NaHCO3, 103 units penicillin, 103 ,tg/ml streptomycin, 0.25 ,tg/ml fungizone, 0.005% neutral red, and 0.0015% phenol red. The cells were incubated at 37°C for 2-3 days until plaques could be observed and counted (17) .
RESULTS
Construction of Full-Length cDNA Clones of IBDV Genome. To develop a reverse genetics system for the dsRNA virus IBDV, two independent cDNA clones were constructed that contain segment A of strain D78 and segment B of strain P2 (Fig. 1) . Each plasmid encoded either the precursor of structural proteins (VP2, VP4, VP3) and VP5 or only VP1 protein (RNA-dependent RNA polymerase). Plasmid pUC18FLBP2, upon digestion with PstI and transcription in vitro by T7 RNA polymerase, would yield RNA containing the correct 5' and 3' ends. Similarly, upon digestion with BsrGI and transcription, plasmid pUC19FLAD78 would yield RNA containing the correct 5' end, but with an additional four nucleotides at the 3' end. Coupled transcription and translation of the above plasmids in a rabbit reticulocyte system yielded protein products that were correctly processed. These products comigrated with the marker IBDV proteins after fractionation on SDS/polyacrylamide gel and autoradiography (data not shown).
Transcription, Transfection, and Generation of a Chimeric Infectious Virus. Plus-sense transcripts of serotype I IBDV segments A and B were synthesized separately in vitro with T7 RNA polymerase, using linearized full-length cDNA plasmids as templates (Fig. 2) . Although two species of RNA transcripts were observed for segment B on a neutral gel (lanes 1 and 5), fractionation of these samples on a denaturing gel yielded only one transcript-specific band (data not shown). To show that Identification of Sequence Tags. To demonstrate the utility of the reverse genetics system, two recombinant IBDVs were generated, which contain sequence tags in segments A and B, respectively. In plasmid pUC19FLAD78mut, the IBDV nucleotide sequence was altered by oligonucleotide-directed mutagenesis to create unique NheI and SpeI restriction sites in the VP2 gene. Synthetic transcripts of this modified segment A of strain D78 and segment B of strain P2 were then used to transfect Vero cells. To verify that these sites were present in the recovered virus, the genomic RNA was purified from the virions and analyzed after RT-PCR or PCR amplifications using segment A specific primers. The presence of the genetic tag in the transfectant virus was confirmed by digestion of the PCR products with the appropriate restriction enzymes, as shown in Fig. 3 . Sequences from mock-infected Vero cells and transfectant viruses (with and without the genetic tag in segment A) were reverse transcribed and amplified in parallel.
An 1184-bp fragment was obtained from both transfectant viruses (lanes 5 and 6) but not from Vero cells (lane 4). No product was obtained when reverse transcriptase was omitted from the reactions before PCR (lanes 1-3) , indicating that the PCR product was derived from RNA, not from contaminating DNA. After digestion with NheI and Spel, expected fragments of 769 bp and 415 bp (lane 8), and 1049 bp (lane 10; 135 bp not 1-3) . Purified RT-PCR fragments, derived from the transfectant viruses, were digested with NheI and SpeI restriction enzymes, as indicated (lanes 7-10). Only the DNA fragment derived from the tagged virus was able to be digested, thus verifying the presence of these two restriction sites (lanes 8 and 10), whereas the one derived from the control transfectant virus remains undigested (lanes 7 and 9). A DNA, digested with HindIll/EcoRI, was used as a marker (lane M).
shown) were obtained from the tagged-viral RNA segment A, whereas the PCR product derived from the unmodified viral RNA remained undigested (lanes 7 and 9) .
Similarly, the IBDV nucleotide sequence in segment B was altered by oligonucleotide-directed mutagenesis to introduce three silent mutations at nucleotide positions 1770 (G -> C), 1773 (T --C), and 1776 (G --C) in the VP1 gene. Vero cells were transfected with the synthetic transcripts derived from plasmids pUC18FLBP2mut and pUC19FLAD78, and the transfectant virus was recovered as described. Simultaneously, the unmodified transfectant virus was also recovered. After two passages in CEC, the genomic RNA of these viruses was cloned by RT-PCR using a specific primer pair of segment B, and then sequenced. No product was obtained when reverse transcriptase was omitted from the reactions before PCR, indicating that the derived RT-PCR product was not the result of contaminating DNA (data not shown). Sequence analysis of the cloned fragment of transfectant viruses exhibits the expected nucleotide mutations, as shown in Fig. 4 DNA, corresponding to the entire genome of a segmented dsRNA animal virus, can give rise to a replicating virus. The recovery of infectious virus after transfecting cells with synthetic plus-sense RNAs, derived from cloned cDNA of a virus with dsRNA genome (IBDV), completes the quest of generating reverse infectious systems for RNA viruses. A number of investigators have generated infectious RNA viruses from cloned cDNA using synthetic transcripts (11). Racaniello and Baltimore were first to rescue poliovirus, a plus-stranded RNA virus, using cloned cDNA (12) . Later, van (IBDV) . In this regard, the system was comparable to other rescue systems of plus-stranded poliovirus and double-stranded hypovirus (18, 19) . The fate of the additional one and four nucleotides, respectively, transcribed at the 3' end of segment A, was not determined. Obviously, this did not prevent the replication of the viral dsRNA. Similar effects have been observed in plus-stranded RNA viruses by different investigators (1 1).
Transfection of plus-sense RNAs from both segments into the same cell was necessary for the successful recovery of IBDV. Transfected RNAs of both segments had to be translated by the cellular translation machinery. The polyprotein of segment A was presumably processed into VP2, VP3, and VP4 proteins, which form the viral capsid. The translated protein VP1 of segment B probably acted as an RNA-dependent RNA polymerase and transcribed minus-strands from synthetic plusstrands of both segments, and the reaction products formed dsRNA. Recently, Dobos reported that in vitro transcription by the virion RNA-dependent RNA polymerase of infectious pancreatic necrosis virus, a prototype virus of the Birnaviridae family, is primed by VP1 and then proceeds via an asymmetric, semiconservative, strand-displacement mechanism to synthesize only plus-strands during replication of the viral genome (20) . Our system showed that synthesis of minus strands must proceed on the plus strands. Whether the resulting transcribed minus-strand RNA serves as a template for the transcription of plus-strands or not remains the subject of further investigations.
To unequivocally prove that the infectious virus (IBDV) contained in supernatants of transfected cells was indeed derived from the synthetic transcripts, two recombinant viruses were generated containing sequence tags in either segment A of strain D78 or segment B of strain P2. Restriction enzyme digests of the RT-PCR products and sequence analysis of the cloned DNA fragments verified the presence of these sequence tags in the genomic RNA segments.
The recovery of infectious virus (IBDV) demonstrated that only the plus-strand RNAs of both segments were sufficient to initiate replication of dsRNA. Thus, results are in agreement with the general features of reovirus and rotavirus replication, where the plus-strand RNAs serve as a template for the synthesis of progeny minus-strands to yield dsRNA (21-23).
However, the semiconservative strand displacement mechanisms proposed by Spies et al. (6) and Dobos (20) could not be excluded. The development of a reverse genetics system for IBDV will greatly facilitate future studies of gene expression and pathogenesis, and help in the design of a new generation of live IBDV vaccines.
